Skip to main content
Log in

Healing of tibial and calvarial bone defect using Runx-2-transfected adipose stem cells

  • Original Article
  • Tissue Engineering
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

The purpose of this study was to test the effect of Runx-2-transfected hASCs to heal the defect created on proximal tibiae and calvaria of immunosuppressed rats. Three kinds of hASCs (untransfected, pECFP-transfected ASCs or Runx-2-transfected ASCs) were cultured under osteogenic medium. Osteoblastic differentiation was measured by ALP staining on day 7 and osteoid matrix formation was observed by alizarin red staining on day 14 after osteogenic induction. Osteogenic potential in long bone defects were tested via 6 mm-sized circular defect on proximal tibiae of 9 immunosuppressed rats. Untransfected ASCs, pECFP-transfected ASCs or Runx-2-transfected ASCs embedded in fibrin scaffold were implanted in the defect (N=3 in each group). In order to assess the in vivo osteogenic capability of Runx-2-transfected ASC in intramembanous ossification, two critical size bone defects were created on parietal bone of 12 immunosuppressed rats. The defects were filled with fibrin scaffold containing pECFP-transfected ASCs, Runx-2-transfected ASCs or no cell (N=4 in each group). Runx-2 transfected ASCs showed much stronger activity of ALP and greater formation of osteoid matrix compared with untransfected ASCs or pECFP-transfected ASCs 7 and 14 after osteo-induction, respectively. When the volume of regenerated bone was compared from gross examination and radiographs after 5 weeks in the proximal tibial defect model, the defects treated with Runx-2-transfected ASCs had the greatest area of healed bone compared with other groups. In the calvarial defect model, Runx-2-transfected ASCs had significantly increased area healed with bone (p<0.05) as well as better quality of regenerated bone compared with defects which was treated with untransfected ASCs from gross and micro-CT examination 8 weeks after implantation. The implanted human cells persisted in the newly regenerated bone in defects treated with pECFP-ASCs and Runx-2-transfected ASCs. In conclusion, Runx-2-transfection significantly increased the osteogenic potential of ASCs in the in vivo orthotopic models.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. TA Einhorn, The science of fracture healing, J Orthop Trauma, 19, S4 (2005).

    Article  Google Scholar 

  2. JO Hollinger, JC Kleinschmidt, The critical size defect as an experimental model to test bone repair materials, J Craniofac Surg, 1, 60 (1990).

    Article  CAS  PubMed  Google Scholar 

  3. MD McKee, Management of segmental bony defects: the role of osteoconductive orthobiologics, J Am Acad Orthop Surg, 14, S163 (2006).

    Google Scholar 

  4. CH Evans, Gene therapy for bone healing, Expert Rev Mol Med, 12, e18 (2010).

    Article  Google Scholar 

  5. DH Kim, R Rhim, L Li, et al., Prospective study of iliac crest bone graft harvest site pain and morbidity, Spine J, 9, 886 (2009).

    Article  PubMed  Google Scholar 

  6. C Delloye, O Cornu, V Druez, et al., Bone allografts: What they can offer and what they cannot, J Bone Joint Surg Br, 89, 574 (2007).

    Article  CAS  PubMed  Google Scholar 

  7. PA Zuk, M Zhu, P Ashjian, et al., Human adipose tissue is a source of multipotent stem cells, Mol Biol Cell, 13, 4279 (2002).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. PA Zuk, M Zhu, H Mizuno, et al., Multilineage cells from human adipose tissue: implications for cell-based therapies, Tissue Eng, 7, 211 (2001).

    Article  CAS  PubMed  Google Scholar 

  9. S Nathan, De S Das, A Thambyah, et al., Cell-based therapy in the repair of osteochondral defects: a novel use for adipose tissue, Tissue Eng, 9, 733 (2003).

    Article  CAS  PubMed  Google Scholar 

  10. GR Erickson, JM Gimble, DM Franklin, et al., Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo, Biochem Biophys Res Commun, 290, 763 (2002).

    Article  CAS  PubMed  Google Scholar 

  11. YD Halvorsen, D Franklin, AL Bond, et al., Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells, Tissue Eng, 7, 729 (2001).

    Article  CAS  PubMed  Google Scholar 

  12. GI Im, YW Shin, KB Lee, Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage, 13, 845 (2005).

    Article  PubMed  Google Scholar 

  13. SP Bruder, BS Fox, Tissue engineering of bone. Cell based strategies, Clin Orthop Relat Res, 367 Suppl, S68 (1999).

    Article  Google Scholar 

  14. G Turgeman, DD Pittman, R Muller, et al., Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy, J Gene Med, 3, 240 (2001).

    Article  CAS  PubMed  Google Scholar 

  15. J Park, J Ries, K Gelse et al., Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes, Gene Ther, 10, 1089 (2003).

    Article  CAS  PubMed  Google Scholar 

  16. H Tsuda, T Wada, Y Ito, et al., Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fibermutant adenoviral vector, Mol Ther, 7, 354 (2003).

    Article  CAS  PubMed  Google Scholar 

  17. Z Zhao, Z Wang, C Ge, et al., Healing cranial defects with AdRunx2-transduced marrow stromal cells, J Dent Res, 86, 1207 (2007).

    Article  CAS  PubMed  Google Scholar 

  18. Z Zhao, M Zhao, G Xiao, et al., Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo, Mol Ther, 12, 247 (2005).

    Article  CAS  PubMed  Google Scholar 

  19. T Komori, H Yagi, S Nomura, et al., Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts, Cell, 89, 755 (1997).

    Article  CAS  PubMed  Google Scholar 

  20. F Otto, AP Thornell, T Crompton, et al., Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development, Cell, 89, 765 (1997).

    Article  CAS  PubMed  Google Scholar 

  21. T Komori, Regulation of osteoblast differentiation by transcription factors, J Cell Biochem, 99, 1233 (2006).

    Article  CAS  PubMed  Google Scholar 

  22. F Otto, H Kanegane, S Mundlos, Mutations in the RUNX2 gene in patients with cleidocranial dysplasia, Hum Mutat, 19, 209 (2002).

    Article  CAS  PubMed  Google Scholar 

  23. JS Lee, JM Lee, GI Im, Electroporation-mediated transfer of Runx2 and Osterix genes to enhance osteogenesis of adipose stem cells, Biomaterials, 32, 760 (2011).

    Article  CAS  PubMed  Google Scholar 

  24. BA Byers, RE Guldberg, DW Hutmacher, et al., Effects of Runx2 genetic engineering and in vitro maturation of tissueengineered constructs on the repair of critical size bone defects, J Biomed Mater Res A, 76, 646 (2006).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gun-Il Im.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, J.M., Kim, E.A. & Im, GI. Healing of tibial and calvarial bone defect using Runx-2-transfected adipose stem cells. Tissue Eng Regen Med 12, 107–112 (2015). https://doi.org/10.1007/s13770-014-0070-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13770-014-0070-3

Key words

Navigation